TipRanks on MSN
Amgen’s Avacopan Study: A Closer Look at Long-term Safety in ANCA-associated Vasculitis
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 4 clinical trial ...
Avacopan treatment for antineutrophil cytoplasmic antibody–associated vasculitis demonstrated lower rates of adverse events, serious adverse events, white blood cell (WBC) count reductions, and ...
Researchers in Japan showed that a unique neutrophil subset, characterized by type II interferon signature genes (T2ISG), along with elevated levels of interferon gamma in the blood, can predict the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback